This study aimed to analyze the clinical characteristics, discharge rate, and fatality rate of COVID-19 patients from December 2019 to February 2020. Data from 10 studies involving 1994 patients were included in the meta-analysis. The main clinical symptoms were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Laboratory findings showed lymphocytopenia (64.5%), increased C-reactive protein (44.3%), increased lactic dehydrogenase (28.3%), and leukocytopenia (29.4%). The male-to-female ratio was 60% (95% CI [0.54, 0.65]), with a discharge rate of 52% (95% CI [0.34, 0.70]) and a fatality rate of 5% (95% CI [0.01, 0.11]). The study suggests that males are more affected, and the fatality rate is lower compared to SARS-CoV and MERS-CoV. The findings highlight the importance of early detection and management to reduce transmission and improve outcomes.This study aimed to analyze the clinical characteristics, discharge rate, and fatality rate of COVID-19 patients from December 2019 to February 2020. Data from 10 studies involving 1994 patients were included in the meta-analysis. The main clinical symptoms were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Laboratory findings showed lymphocytopenia (64.5%), increased C-reactive protein (44.3%), increased lactic dehydrogenase (28.3%), and leukocytopenia (29.4%). The male-to-female ratio was 60% (95% CI [0.54, 0.65]), with a discharge rate of 52% (95% CI [0.34, 0.70]) and a fatality rate of 5% (95% CI [0.01, 0.11]). The study suggests that males are more affected, and the fatality rate is lower compared to SARS-CoV and MERS-CoV. The findings highlight the importance of early detection and management to reduce transmission and improve outcomes.